Rodney E. Rohde
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rodney E. Rohde has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Amber Hogan Mitchell
The International Safety Center, Apopka, FL
4 shared publicationsJulie Reagan
Georgia Southern University, Jiann-Ping Hsu College of Public Health, Statesboro, GA
4 shared publicationsMarilyn Felkner
Emerging and Acute Infectious Disease Branch (EAIDB), Infectious Disease Control Unit, Texas Department of State Health Services (DSHS), Austin, TX
4 shared publicationsPat Tille
Medical Laboratory Science, College of Pharmacy, South Dakota State University, SD
4 shared publicationsBonny C. Mayes
Texas Department of State Health Services
2 shared publicationsEmillio Carranco
Texas State University, Student Health Center, San Marcos, TX
2 shared publications
Latest Publications
- 13 June 2025
- Published by Springer Nature
- p. 143-216
Texas Tales, Trivia, and Teasers: Rabies Through the Decades
- 13 June 2025
- Published by Springer Nature
- p. 143-216
Texas Tales, Trivia, and Teasers: Rabies Through the Decades
- 27 June 2024
- Published by Springer Nature
- p. 143-159
COVID-19 and Uncertain Times
- Open Access
- 1 January 2016
- Published by American Society for Clinical Laboratory Science in American Society for Clinical Laboratory Science
- Vol. 29 (1) , 32-38
The Perfect Storm: Emerging Trends and Pathogens in Healthcare
1. Pat Tille, PhD, MT(ASCP) 1. Medical Laboratory Science, College of Pharmacy, South Dakota State University, SD 2. Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM[⇑][1] 1. Clinical Laboratory Science Program, College of Health Professions, Texas State University, San Marcos, TX 3. Julie Reagan, PhD, JD, MPH 1. Georgia Southern University, Jiann-Ping Hsu College of Public Health, Statesboro, GA 4. Marilyn Felkner, DrPH, MT(ASCP) 1. Emerging and Acute Infectious Disease Branch (EAIDB), Infectious Disease Control Unit, Texas Department of State Health Services (DSHS), Austin, TX 5. Amber Hogan Mitchell, DrPH, MPH, CPH 1. The International Safety Center, Apopka, FL 1. Address for Correspondence: Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM, Professor & Chair, CLS Program; Associate Dean for Research, Clinical Laboratory Science Program, College of Health Professions, Texas State University, 601 University Drive, San Marcos, TX 78666, 512-245-2562, 512-245-7860, rrohde{at}txstate.edu 1. Explain how vulnerable populations, current healthcare delivery, and emerging pathogens have contributed to an increase in healthcare-associated infections. 2. Compare and contrast pathogens that occur in persons with HIV/AIDS, persons with cancer, and persons undergoing transplants. 3. Identify ways that community-based healthcare delivery may increase risk of HAIs. 4. Discuss the role of antibiotic overuse and international travel in the development of emerging pathogens. 5. Plan activities that are effective in preventing HAIs. INTRODUCTION In 1999, the article To Err is Human brought healthcare-associated infections (HAI) to the nation's attention. However, the risk posed by healthcare facilities to those who went there for healing had not developed overnight. Decades of changing demography, microbial evolution, and –ironically-- healthcare advancements had resulted in this perfect storm. Since the change in paradigm in healthcare that nosocomial or healthcare-associated infections are a natural consequence of treatment to a practice of surveillance and prevention, hospital acquired infections are no longer considered consequences of inpatient treatment. Prevention of healthcare-associated infections includes protecting patients, healthcare workers, visitors, volunteers and health science students. This paper aims to describe the contributory roles of affected populations with their attendant, diverse healthcare sites and healthcare workers, and emerging pathogens. Affected Populations Prior to the identification of the Acquired Immune Deficiency (AIDS) virus, persons with chronic immune deficiencies were anomalies—“bubble children” who were occasionally brought to the public's attention through the media. With the advent of HIV/AIDS, healthcare facilities faced the daunting task of caring for many individuals with immune deficiency on a long-term basis. Just as many infectious diseases seemed to have been conquered through vaccine or antibiotics, healthcare was called upon to manage a new infectious disease with no treatment and also to protect those individuals from other potential infections including pathogens that did not cause disease in persons with healthy immune systems. HIV/AIDS required healthcare facilities not only to protect their patients but their workers from a high fatality disease that was… ABBREVIATIONS: AIDS – Acquired Immune Deficiency Syndrome, CA-MRSA – Community-Associated Methicillin Resistant Staphylococcus aureus , CDC – Centers for Disease Control and Prevention, CRE - carbapenem-resistant Enterobacteriaceae, CMV – Cytomegalovirus, FDA - Food and Drug Administration, HA-MRSA – Healthcare-Associated Methicillin Resistant Staphylococcus aureus , HAI – Healthcare-Associated Infections, HCW – Healthcare Worker, HIV – Human Immunodeficiency Virus, KPC-Kp – Klebsiella pneumoniae Carbapenemase Producing, MERS – Middle Eastern Respiratory Syndrome, MDRO – Multiple Drug Resistant Organisms, MRSA – Methicillin Resistant Staphylococcus aureus , NICU – Neonatal Intensive Care Unit, NHSN – National Health Safety Network, PPE – Personal Protective Equipment, RSV – Respiratory Syncitial Virus, VRE - Vancomycin-resistant Enterococci 1. Explain how vulnerable populations, current healthcare delivery, and emerging pathogens have contributed to an increase in healthcare-associated infections. 2. Compare and contrast pathogens that occur in persons with HIV/AIDS, persons with cancer, and persons undergoing transplants. 3. Identify ways that community-based healthcare delivery may increase risk of HAIs. 4. Discuss the role of antibiotic overuse and international travel in the development of emerging pathogens. 5. Plan activities that are effective in preventing HAIs. [1]: #corresp-1
- 1 January 2016
- Published by American Society for Clinical Laboratory Science in American Society for Clinical Laboratory Science
- Vol. 29 (1) , 32-38
Open AccessThe Perfect Storm: Emerging Trends and Pathogens in Healthcare
1. Pat Tille, PhD, MT(ASCP) 1. Medical Laboratory Science, College of Pharmacy, South Dakota State University, SD 2. Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM[⇑][1] 1. Clinical Laboratory Science Program, College of Health Professions, Texas State University, San Marcos, TX 3. Julie Reagan, PhD, JD, MPH 1. Georgia Southern University, Jiann-Ping Hsu College of Public Health, Statesboro, GA 4. Marilyn Felkner, DrPH, MT(ASCP) 1. Emerging and Acute Infectious Disease Branch (EAIDB), Infectious Disease Control Unit, Texas Department of State Health Services (DSHS), Austin, TX 5. Amber Hogan Mitchell, DrPH, MPH, CPH 1. The International Safety Center, Apopka, FL 1. Address for Correspondence: Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM, Professor & Chair, CLS Program; Associate Dean for Research, Clinical Laboratory Science Program, College of Health Professions, Texas State University, 601 University Drive, San Marcos, TX 78666, 512-245-2562, 512-245-7860, rrohde{at}txstate.edu 1. Explain how vulnerable populations, current healthcare delivery, and emerging pathogens have contributed to an increase in healthcare-associated infections. 2. Compare and contrast pathogens that occur in persons with HIV/AIDS, persons with cancer, and persons undergoing transplants. 3. Identify ways that community-based healthcare delivery may increase risk of HAIs. 4. Discuss the role of antibiotic overuse and international travel in the development of emerging pathogens. 5. Plan activities that are effective in preventing HAIs. INTRODUCTION In 1999, the article To Err is Human brought healthcare-associated infections (HAI) to the nation's attention. However, the risk posed by healthcare facilities to those who went there for healing had not developed overnight. Decades of changing demography, microbial evolution, and –ironically-- healthcare advancements had resulted in this perfect storm. Since the change in paradigm in healthcare that nosocomial or healthcare-associated infections are a natural consequence of treatment to a practice of surveillance and prevention, hospital acquired infections are no longer considered consequences of inpatient treatment. Prevention of healthcare-associated infections includes protecting patients, healthcare workers, visitors, volunteers and health science students. This paper aims to describe the contributory roles of affected populations with their attendant, diverse healthcare sites and healthcare workers, and emerging pathogens. Affected Populations Prior to the identification of the Acquired Immune Deficiency (AIDS) virus, persons with chronic immune deficiencies were anomalies—“bubble children” who were occasionally brought to the public's attention through the media. With the advent of HIV/AIDS, healthcare facilities faced the daunting task of caring for many individuals with immune deficiency on a long-term basis. Just as many infectious diseases seemed to have been conquered through vaccine or antibiotics, healthcare was called upon to manage a new infectious disease with no treatment and also to protect those individuals from other potential infections including pathogens that did not cause disease in persons with healthy immune systems. HIV/AIDS required healthcare facilities not only to protect their patients but their workers from a high fatality disease that was… ABBREVIATIONS: AIDS – Acquired Immune Deficiency Syndrome, CA-MRSA – Community-Associated Methicillin Resistant Staphylococcus aureus , CDC – Centers for Disease Control and Prevention, CRE - carbapenem-resistant Enterobacteriaceae, CMV – Cytomegalovirus, FDA - Food and Drug Administration, HA-MRSA – Healthcare-Associated Methicillin Resistant Staphylococcus aureus , HAI – Healthcare-Associated Infections, HCW – Healthcare Worker, HIV – Human Immunodeficiency Virus, KPC-Kp – Klebsiella pneumoniae Carbapenemase Producing, MERS – Middle Eastern Respiratory Syndrome, MDRO – Multiple Drug Resistant Organisms, MRSA – Methicillin Resistant Staphylococcus aureus , NICU – Neonatal Intensive Care Unit, NHSN – National Health Safety Network, PPE – Personal Protective Equipment, RSV – Respiratory Syncitial Virus, VRE - Vancomycin-resistant Enterococci 1. Explain how vulnerable populations, current healthcare delivery, and emerging pathogens have contributed to an increase in healthcare-associated infections. 2. Compare and contrast pathogens that occur in persons with HIV/AIDS, persons with cancer, and persons undergoing transplants. 3. Identify ways that community-based healthcare delivery may increase risk of HAIs. 4. Discuss the role of antibiotic overuse and international travel in the development of emerging pathogens. 5. Plan activities that are effective in preventing HAIs. [1]: #corresp-1
- 1 January 2016
- Published by American Society for Clinical Laboratory Science in American Society for Clinical Laboratory Science
- Vol. 29 (1) , 39-43
The Legal Landscape: HAI Public Reporting in the United States
1. Julie Reagan, PhD, JD, MPH 1. Georgia Southern University, Jiann-Ping Hsu College of Public Health, Statesboro, GA 2. Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM[⇑][1] 1. Clinical Laboratory Science Program, College of Health Professions, Texas State University, San Marcos, TX 3. Amber Hogan Mitchell, DrPH, MPH, CPH 1. The International Safety Center, Apopka, FL 4. Marilyn Felkner, DrPH, MT(ASCP) 1. Emerging and Acute Infectious Disease Branch (EAIDB), Infectious Disease Control Unit, Texas Department of State Health Services (DSHS), Austin, TX 5. Pat Tille, PhD, MT(ASCP) 1. Medical Laboratory Science, College of Pharmacy, South Dakota State University, SD 1. Address for Correspondence: Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM, Professor & Chair, CLS Program; Associate Dean for Research, Clinical Laboratory Science Program, College of Health Professions, Texas State University, 601 University Drive, San Marcos, TX 78666, 512-245-2562, 512-245-7860, rrohde{at}txstate.edu 1. Discuss the role of federal influences on state-level HAI program initiatives and reporting activities. 2. Describe the progression of state-level initiatives to reduce HAIs from 2004 to the current date. 3. Describe core provisions of state HAI reporting laws: surveillance, collection system, healthcare settings subject to the laws, types of infections reported, public reporting requirements, and advisory committee structure. 4. Identify healthcare worker infection and illness reporting mandates. INTRODUCTION Since early 2000, there has been a “growing interest in the use of law as a tool to address” healthcare-associated infections (HAIs) in the U.S.1 All 50 states and two territories have HAI programs established within their public health agencies.2 Likewise, the majority of states have HAI public reporting laws.3-4 HAI data is being reported from hospitals in all 50 states, either voluntarily or under state or federal legal reporting mandates.5 Additionally, while the current national focus is on reporting HAIs in the patient population, requirements for reporting infections and illness in the healthcare worker population also exists. The purpose of this article is to provide a review of the federal and state-level legal environment applicable to HAI prevention in the context of the overall response to HAIs. Federal Influences To fully grasp state-level HAI program initiatives and reporting activities, it is important first to understand the many federal influences. Through the U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC), the federal government plays a central role in the control and prevention of HAIs. From 2004 to 2008, states began to recognize the need for state policies aimed at HAI prevention.4 Several states made significant strides toward HAI surveillance and prevention as the awareness of the public health impact of HAIs grew. However, due to budget constraints and the associated poor economic conditions starting in 2008, most states were unable to implement or further develop their HAI programs. Significant improvements… ABBREVIATIONS: ACA – The Patient Protection and Affordable Care Act, CDC – Centers for Disease Control and Prevention, CMS – Centers for Medicare and Medicaid Services, CLABSI – central line-associated bloodstream infection, CAUTI – catheter-associated urinary tract infection, CRE – Carbepenem-resistant Enterobacteriaceae, HAIs – healthcare-associated infections, HHS – U.S. Department of Health and Human Services, IQR – Inpatient Quality Reporting Program, MRSA -- Methicillin Resistant Staphylococcus aureus , NHSN – National Healthcare Safety Network, OSHA – Occupational Safety and Health Administration, VAP – ventilator-associated pneumonia 1. Discuss the role of federal influences on state-level HAI program initiatives and reporting activities. 2. Describe the progression of state-level initiatives to reduce HAIs from 2004 to the current date. 3. Describe core provisions of state HAI reporting laws: surveillance, collection system, healthcare settings subject to the laws, types of infections reported, public reporting requirements, and advisory committee structure. 4. Identify healthcare worker infection and illness reporting mandates. [1]: #corresp-1
- 1 January 2016
- Published by American Society for Clinical Laboratory Science in American Society for Clinical Laboratory Science
- Vol. 29 (1) , 39-43
The Legal Landscape: HAI Public Reporting in the United States
1. Julie Reagan, PhD, JD, MPH 1. Georgia Southern University, Jiann-Ping Hsu College of Public Health, Statesboro, GA 2. Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM[⇑][1] 1. Clinical Laboratory Science Program, College of Health Professions, Texas State University, San Marcos, TX 3. Amber Hogan Mitchell, DrPH, MPH, CPH 1. The International Safety Center, Apopka, FL 4. Marilyn Felkner, DrPH, MT(ASCP) 1. Emerging and Acute Infectious Disease Branch (EAIDB), Infectious Disease Control Unit, Texas Department of State Health Services (DSHS), Austin, TX 5. Pat Tille, PhD, MT(ASCP) 1. Medical Laboratory Science, College of Pharmacy, South Dakota State University, SD 1. Address for Correspondence: Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM, Professor & Chair, CLS Program; Associate Dean for Research, Clinical Laboratory Science Program, College of Health Professions, Texas State University, 601 University Drive, San Marcos, TX 78666, 512-245-2562, 512-245-7860, rrohde{at}txstate.edu 1. Discuss the role of federal influences on state-level HAI program initiatives and reporting activities. 2. Describe the progression of state-level initiatives to reduce HAIs from 2004 to the current date. 3. Describe core provisions of state HAI reporting laws: surveillance, collection system, healthcare settings subject to the laws, types of infections reported, public reporting requirements, and advisory committee structure. 4. Identify healthcare worker infection and illness reporting mandates. INTRODUCTION Since early 2000, there has been a “growing interest in the use of law as a tool to address” healthcare-associated infections (HAIs) in the U.S.1 All 50 states and two territories have HAI programs established within their public health agencies.2 Likewise, the majority of states have HAI public reporting laws.3-4 HAI data is being reported from hospitals in all 50 states, either voluntarily or under state or federal legal reporting mandates.5 Additionally, while the current national focus is on reporting HAIs in the patient population, requirements for reporting infections and illness in the healthcare worker population also exists. The purpose of this article is to provide a review of the federal and state-level legal environment applicable to HAI prevention in the context of the overall response to HAIs. Federal Influences To fully grasp state-level HAI program initiatives and reporting activities, it is important first to understand the many federal influences. Through the U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC), the federal government plays a central role in the control and prevention of HAIs. From 2004 to 2008, states began to recognize the need for state policies aimed at HAI prevention.4 Several states made significant strides toward HAI surveillance and prevention as the awareness of the public health impact of HAIs grew. However, due to budget constraints and the associated poor economic conditions starting in 2008, most states were unable to implement or further develop their HAI programs. Significant improvements… ABBREVIATIONS: ACA – The Patient Protection and Affordable Care Act, CDC – Centers for Disease Control and Prevention, CMS – Centers for Medicare and Medicaid Services, CLABSI – central line-associated bloodstream infection, CAUTI – catheter-associated urinary tract infection, CRE – Carbepenem-resistant Enterobacteriaceae, HAIs – healthcare-associated infections, HHS – U.S. Department of Health and Human Services, IQR – Inpatient Quality Reporting Program, MRSA -- Methicillin Resistant Staphylococcus aureus , NHSN – National Healthcare Safety Network, OSHA – Occupational Safety and Health Administration, VAP – ventilator-associated pneumonia 1. Discuss the role of federal influences on state-level HAI program initiatives and reporting activities. 2. Describe the progression of state-level initiatives to reduce HAIs from 2004 to the current date. 3. Describe core provisions of state HAI reporting laws: surveillance, collection system, healthcare settings subject to the laws, types of infections reported, public reporting requirements, and advisory committee structure. 4. Identify healthcare worker infection and illness reporting mandates. [1]: #corresp-1
- Open Access
- 1 January 2016
- Published by American Society for Clinical Laboratory Science in American Society for Clinical Laboratory Science
- Vol. 29 (1) , 44-48
The Changing Role of the Healthcare Environment
1. Amber Hogan Mitchell, DrPH, MPH, CPH 1. The International Safety Center, Apopka, FL 2. Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM[⇑][1] 1. Clinical Laboratory Science Program, College of Health Professions, Texas State University, San Marcos, TX 3. Pat Tille, PhD, MT(ASCP) 1. Medical Laboratory Science, College of Pharmacy, South Dakota State University, SD 4. Julie Reagan, PhD, JD, MPH 1. Georgia Southern University, Jiann-Ping Hsu College of Public Health, Statesboro, GA 5. Marilyn Felkner, DrPH, MT(ASCP) 1. Emerging and Acute Infectious Disease Branch (EAIDB), Infectious Disease Control Unit, Texas Department of State Health Services (DSHS), Austin, TX 1. Address for Correspondence: Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM, Professor & Chair, CLS Program; Associate Dean for Research, Clinical Laboratory Science Program, College of Health Professions, Texas State University, 601 University Drive, San Marcos, TX 78666, 512-245-2562, 512-245-7860, rrohde{at}txstate.edu 1. Describe the role of the healthcare environment in its contribution to acquisition and transfer of microorganisms. 2. Discuss the role the environment has related to the risk of infection and illness in both patient and healthcare worker populations. 3. Summarize recently published scientific evidence related to transmission of microbes from environmental surfaces including textiles. 4. Explore laundering practices and procedures of healthcare textiles and uniforms. 5. Discuss new technologies and programs that can address reducing risk associated with contaminated environmental surfaces. INTRODUCTION The role of the healthcare environment and its contribution to acquisition and transfer of microorganisms that cause infection and illness in both patients and healthcare workers is not by any means straightforward. Considerations include potential contamination of hard surfaces like desks, sinks, beds, light switches, carts, walls, and floors, as well as porous surfaces like wheelchairs, bedding, linen, curtains, and upholstery. Historically the focus on managing the role of environmental variables was considered less critical because we knew less about the impact those surfaces had in infection prevention. Several factors are now monitored within healthcare settings that are considered environmental controls. One of the primary areas includes environmental surfaces. These have been categorized by the Spaulding Classification as “noncritical items” or those that do not come into contact with a patient's vascular system or body cavities, but rather simply by a brief or momentary touch from a patient or healthcare worker.1 Critical or semi-critical items, in contrast to environmental or touch surfaces, are medical devices that are either implanted into a patient like joints, stints or other devices used during medical or surgical procedures like scalpels, endoscopes or probes that are in contact with a patient for minutes, hours, weeks, or years. These items pose a higher risk than noncritical items because they come into direct contact with a patient's blood or body fluids. This year, the U.S. witnessed how improper cleaning and disinfection or sterilization or medical devices like endoscopes can result in serious patient illness and infection,… ABBREVIATIONS: ACHA – American College of Healthcare Architects, AHE - Association for the Healthcare Environment, CRE - carbapenem-resistant Enterobacteriaceae, CDC – Centers for Disease Control and Prevention, CDI – Clostridium difficile Infection, CFU – Colony Forming Units, EVS – Environmental Services, FDA - Food and Drug Administration, HCW – Healthcare Worker, HICPAC – Healthcare Infection Control Practices Advisory Committee, MDRO – Multiple Drug Resistant Organisms, MRSA – Methicillin Resistant Staphylococcus aureus , OR – Operating Room, OSHA - Occupational Safety and Health Administration, PPE – Personal Protective Equipment, VRE - Vancomycin-resistant Enterococci 1. Describe the role of the healthcare environment in its contribution to acquisition and transfer of microorganisms. 2. Discuss the role the environment has related to the risk of infection and illness in both patient and healthcare worker populations. 3. Summarize recently published scientific evidence related to transmission of microbes from environmental surfaces including textiles. 4. Explore laundering practices and procedures of healthcare textiles and uniforms. 5. Discuss new technologies and programs that can address reducing risk associated with contaminated environmental surfaces. [1]: #corresp-1
- 1 January 2016
- Published by American Society for Clinical Laboratory Science in American Society for Clinical Laboratory Science
- Vol. 29 (1) , 44-48
Open AccessThe Changing Role of the Healthcare Environment
1. Amber Hogan Mitchell, DrPH, MPH, CPH 1. The International Safety Center, Apopka, FL 2. Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM[⇑][1] 1. Clinical Laboratory Science Program, College of Health Professions, Texas State University, San Marcos, TX 3. Pat Tille, PhD, MT(ASCP) 1. Medical Laboratory Science, College of Pharmacy, South Dakota State University, SD 4. Julie Reagan, PhD, JD, MPH 1. Georgia Southern University, Jiann-Ping Hsu College of Public Health, Statesboro, GA 5. Marilyn Felkner, DrPH, MT(ASCP) 1. Emerging and Acute Infectious Disease Branch (EAIDB), Infectious Disease Control Unit, Texas Department of State Health Services (DSHS), Austin, TX 1. Address for Correspondence: Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM, Professor & Chair, CLS Program; Associate Dean for Research, Clinical Laboratory Science Program, College of Health Professions, Texas State University, 601 University Drive, San Marcos, TX 78666, 512-245-2562, 512-245-7860, rrohde{at}txstate.edu 1. Describe the role of the healthcare environment in its contribution to acquisition and transfer of microorganisms. 2. Discuss the role the environment has related to the risk of infection and illness in both patient and healthcare worker populations. 3. Summarize recently published scientific evidence related to transmission of microbes from environmental surfaces including textiles. 4. Explore laundering practices and procedures of healthcare textiles and uniforms. 5. Discuss new technologies and programs that can address reducing risk associated with contaminated environmental surfaces. INTRODUCTION The role of the healthcare environment and its contribution to acquisition and transfer of microorganisms that cause infection and illness in both patients and healthcare workers is not by any means straightforward. Considerations include potential contamination of hard surfaces like desks, sinks, beds, light switches, carts, walls, and floors, as well as porous surfaces like wheelchairs, bedding, linen, curtains, and upholstery. Historically the focus on managing the role of environmental variables was considered less critical because we knew less about the impact those surfaces had in infection prevention. Several factors are now monitored within healthcare settings that are considered environmental controls. One of the primary areas includes environmental surfaces. These have been categorized by the Spaulding Classification as “noncritical items” or those that do not come into contact with a patient's vascular system or body cavities, but rather simply by a brief or momentary touch from a patient or healthcare worker.1 Critical or semi-critical items, in contrast to environmental or touch surfaces, are medical devices that are either implanted into a patient like joints, stints or other devices used during medical or surgical procedures like scalpels, endoscopes or probes that are in contact with a patient for minutes, hours, weeks, or years. These items pose a higher risk than noncritical items because they come into direct contact with a patient's blood or body fluids. This year, the U.S. witnessed how improper cleaning and disinfection or sterilization or medical devices like endoscopes can result in serious patient illness and infection,… ABBREVIATIONS: ACHA – American College of Healthcare Architects, AHE - Association for the Healthcare Environment, CRE - carbapenem-resistant Enterobacteriaceae, CDC – Centers for Disease Control and Prevention, CDI – Clostridium difficile Infection, CFU – Colony Forming Units, EVS – Environmental Services, FDA - Food and Drug Administration, HCW – Healthcare Worker, HICPAC – Healthcare Infection Control Practices Advisory Committee, MDRO – Multiple Drug Resistant Organisms, MRSA – Methicillin Resistant Staphylococcus aureus , OR – Operating Room, OSHA - Occupational Safety and Health Administration, PPE – Personal Protective Equipment, VRE - Vancomycin-resistant Enterococci 1. Describe the role of the healthcare environment in its contribution to acquisition and transfer of microorganisms. 2. Discuss the role the environment has related to the risk of infection and illness in both patient and healthcare worker populations. 3. Summarize recently published scientific evidence related to transmission of microbes from environmental surfaces including textiles. 4. Explore laundering practices and procedures of healthcare textiles and uniforms. 5. Discuss new technologies and programs that can address reducing risk associated with contaminated environmental surfaces. [1]: #corresp-1
- 1 January 2016
- Published by American Society for Clinical Laboratory Science in American Society for Clinical Laboratory Science
- Vol. 29 (1) , 28-31
Healthcare-Associated Infections (HAI): The Perfect Storm has Arrived!
1. Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM[⇑][1] 1. Clinical Laboratory Science Program, College of Health Professions, Texas State University, San Marcos, TX 2. Marilyn Felkner, DrPH, MT(ASCP) 1. Emerging and Acute Infectious Disease Branch (EAIDB), Infectious Disease Control Unit, Texas Department of State Health Services (DSHS), Austin, TX 3. Julie Reagan, PhD, JD, MPH 1. Georgia Southern University, Jiann-Ping Hsu College of Public Health, Statesboro, GA 4. Amber Hogan Mitchell, DrPH, MPH, CPH 1. The International Safety Center, Apopka, FL 5. Pat Tille, PhD, MT(ASCP) 1. Medical Laboratory Science, College of Pharmacy, South Dakota State University, SD 1. Address for Correspondence: Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM, Professor & Chair, CLS Program; Associate Dean for Research, Clinical Laboratory Science Program, College of Health Professions, Texas State University, 601 University Drive, San Marcos, TX 78666, 512-245-2562, 512-245-7860, rrohde{at}txstate.edu INTRODUCTION On any given day approximately 1 of every 25 inpatients in U.S. acute care hospitals has at least one healthcare–associated infection (HAI), adding up to about 722,000 infections in 2011. Pneumonia and surgical-site infection are the most common infection types, and Clostridium difficile is the most common pathogen.1 The CDC Multistate Point-Prevalence Survey of Healthcare-Associated Infections, published in the New England Journal of Medicine, used 2011 data from 183 U.S. hospitals to estimate the burden of a wide range of infections in hospital patients. That year, about 721,800 infections occurred in 648,000 hospital patients. About 75,000 patients with HAI died during their hospitalizations. The most common healthcare-associated infections were pneumonia (22%), surgical site infections (22%), gastrointestinal infections (17%), urinary tract infections (13%), and bloodstream infections (10%). The most common germs causing HAI by rank were C. difficile (12%), Staphylococcus aureus , including Methicillin Resistant S. aureus (MRSA, 11%), Klebsiella (10%), E. coli (9%), Enterococcus (9%), and Pseudomonas (7%). Klebsiella and E. coli are members of the Enterobacteriaceae bacteria family, which has become increasingly resistant to last-resort antibiotics known as carbapenems, typically referred to as carbapenem resistant Enterobacteriaceae (CRE).1 Practically, what this means is that over 200 patients will die the day you read this article and every day until the global community is able to address this healthcare crisis. If you do the simple math you will realize this results in about 4% of hospitalized patients who developed one or more HAI due to the care received in the hospital… ABBREVIATIONS: CAUTI – Catheter-associated urinary tract infection, CDC – Centers for Disease Control and Prevention, CLABSI – Central line-associated blood stream infection, EVS – Environmental services, HAI – Healthcare-associated infections, HCW – Healthcare Worker, MRSA – Methicillin resistant Staphylococcus aureus , SSIs – Surgical site infections [1]: #corresp-1
- 1 January 2016
- Published by American Society for Clinical Laboratory Science in American Society for Clinical Laboratory Science
- Vol. 29 (1) , 28-31
Healthcare-Associated Infections (HAI): The Perfect Storm has Arrived!
1. Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM[⇑][1] 1. Clinical Laboratory Science Program, College of Health Professions, Texas State University, San Marcos, TX 2. Marilyn Felkner, DrPH, MT(ASCP) 1. Emerging and Acute Infectious Disease Branch (EAIDB), Infectious Disease Control Unit, Texas Department of State Health Services (DSHS), Austin, TX 3. Julie Reagan, PhD, JD, MPH 1. Georgia Southern University, Jiann-Ping Hsu College of Public Health, Statesboro, GA 4. Amber Hogan Mitchell, DrPH, MPH, CPH 1. The International Safety Center, Apopka, FL 5. Pat Tille, PhD, MT(ASCP) 1. Medical Laboratory Science, College of Pharmacy, South Dakota State University, SD 1. Address for Correspondence: Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM, Professor & Chair, CLS Program; Associate Dean for Research, Clinical Laboratory Science Program, College of Health Professions, Texas State University, 601 University Drive, San Marcos, TX 78666, 512-245-2562, 512-245-7860, rrohde{at}txstate.edu INTRODUCTION On any given day approximately 1 of every 25 inpatients in U.S. acute care hospitals has at least one healthcare–associated infection (HAI), adding up to about 722,000 infections in 2011. Pneumonia and surgical-site infection are the most common infection types, and Clostridium difficile is the most common pathogen.1 The CDC Multistate Point-Prevalence Survey of Healthcare-Associated Infections, published in the New England Journal of Medicine, used 2011 data from 183 U.S. hospitals to estimate the burden of a wide range of infections in hospital patients. That year, about 721,800 infections occurred in 648,000 hospital patients. About 75,000 patients with HAI died during their hospitalizations. The most common healthcare-associated infections were pneumonia (22%), surgical site infections (22%), gastrointestinal infections (17%), urinary tract infections (13%), and bloodstream infections (10%). The most common germs causing HAI by rank were C. difficile (12%), Staphylococcus aureus , including Methicillin Resistant S. aureus (MRSA, 11%), Klebsiella (10%), E. coli (9%), Enterococcus (9%), and Pseudomonas (7%). Klebsiella and E. coli are members of the Enterobacteriaceae bacteria family, which has become increasingly resistant to last-resort antibiotics known as carbapenems, typically referred to as carbapenem resistant Enterobacteriaceae (CRE).1 Practically, what this means is that over 200 patients will die the day you read this article and every day until the global community is able to address this healthcare crisis. If you do the simple math you will realize this results in about 4% of hospitalized patients who developed one or more HAI due to the care received in the hospital… ABBREVIATIONS: CAUTI – Catheter-associated urinary tract infection, CDC – Centers for Disease Control and Prevention, CLABSI – Central line-associated blood stream infection, EVS – Environmental services, HAI – Healthcare-associated infections, HCW – Healthcare Worker, MRSA – Methicillin resistant Staphylococcus aureus , SSIs – Surgical site infections [1]: #corresp-1
- Open Access
Effect of Bacteriophage Infection in Combination with Tobramycin on the Emergence of Resistance in Escherichia coli and Pseudomonas aeruginosa Biofilms
Bacteriophage infection and antibiotics used individually to reduce biofilm mass often result in the emergence of significant levels of phage and antibiotic resistant cells. In contrast, combination therapy in Escherichia coli biofilms employing T4 phage and tobramycin resulted in greater than 99% and 39% reduction in antibiotic and phage resistant cells, respectively. In P. aeruginosa biofilms, combination therapy resulted in a 60% and 99% reduction in antibiotic and PB-1 phage resistant cells, respectively. Although the combined treatment resulted in greater reduction of E. coli CFUs compared to the use of antibiotic alone, infection of P. aeruginosa biofilms with PB-1 in the presence of tobramycin was only as effective in the reduction of CFUs as the use of antibiotic alone. The study demonstrated phage infection in combination with tobramycin can significantly reduce the emergence of antibiotic and phage resistant cells in both E. coli and P. aeruginosa biofilms, however, a reduction in biomass was dependent on the phage-host system.
Open AccessEffect of Bacteriophage Infection in Combination with Tobramycin on the Emergence of Resistance in Escherichia coli and Pseudomonas aeruginosa Biofilms
Bacteriophage infection and antibiotics used individually to reduce biofilm mass often result in the emergence of significant levels of phage and antibiotic resistant cells. In contrast, combination therapy in Escherichia coli biofilms employing T4 phage and tobramycin resulted in greater than 99% and 39% reduction in antibiotic and phage resistant cells, respectively. In P. aeruginosa biofilms, combination therapy resulted in a 60% and 99% reduction in antibiotic and PB-1 phage resistant cells, respectively. Although the combined treatment resulted in greater reduction of E. coli CFUs compared to the use of antibiotic alone, infection of P. aeruginosa biofilms with PB-1 in the presence of tobramycin was only as effective in the reduction of CFUs as the use of antibiotic alone. The study demonstrated phage infection in combination with tobramycin can significantly reduce the emergence of antibiotic and phage resistant cells in both E. coli and P. aeruginosa biofilms, however, a reduction in biomass was dependent on the phage-host system.
- Open Access
- 1 January 2014
- Published by American Society for Clinical Laboratory Science in American Society for Clinical Laboratory Science
- Vol. 27 (1) , 21-31
Staphylococcus, not MRSA? A Final Report of Carriage and Conversion Rates in Nursing Students
OBJECTIVE: To evaluate and characterize staphylococcal carriage, possibly including methicillin-resistant Staphylococcus aureus (MRSA), and conversion rates in nursing students across clinical semester rotations and to describe risk factors. DESIGN: A prospective longitudinal cohort design with six times of measurement. Data collected August 2010 to May 2012. Institutional Review Board approval (2010F5693) SETTING: Texas State University, San Marcos, TX PARTICIPANTS: Eighty-seven nursing students. INTERVENTIONS: A positive MRSA swab was considered an end point for participation. Intervention offered was bactroban (mupirocin) for nasal decolonization and an oral antibiotic, doxycycline; follow-up post treatment collection sample was done to verify decolonization prior to next clinical rotation. MAIN OUTCOME MEASURES: Screening for Staphylococcus aureus and MRSA identification; confirmation and antibiotic susceptibility by Vitek 2; self-administered questionnaires delineating demographics and risk factors; panel logistic regression models by Stata version 13 RESULTS: MRSA colonization did not increase. S. aureus incidence was 17.7 – 26.4%. Staphylococcal species incidence other than S. aureus increased (9.2 – 82.3%). The following odds ratio (OR) associations were found to be statistically significant: boil or skin infections with S. aureus (OR = 2.94, p < .01), working or volunteering in a healthcare facility odds with species other than S. aureus (OR = 4.41, p < .01) and gym and sports facilities odds with S. other (OR 2.45, p < .01). The most frequently occurring species at Wave 5 was S. hominis (21 isolates) while the most frequently occurring species at Wave 6 was S. epidermidis (25 isolates). CONCLUSIONS: MRSA colonization did not increase during longitudinal study. S. aureus colonization remained fairly stable throughout the study (17 – 26%). Species colonization with non S. aureus species (e.g. S. hominis, S. epidermis, S. haemolyticus) increased significantly (9.2 – 82.3%) during clinical rotations. Knowledge of infection control and compliance may have contributed to an absence of MRSA colonization; however, the colonization by other staphylococci has been shown to be a risk factor for MRSA acquisition. ABBREVIATIONS: MRSA = Methicillin-resistant Staphylococcus aureus; CA-MRSA = Community-associated methicillin resistant Staphylococcus aureus; HA-MRSA = Healthcare-associated methicillin resistant Staphylococcus aureus; MSSA = methicillin-sensitive Staphylococcus aureus; CLS = Clinical Laboratory Science; OR = odds ratio; CI = Confidence Interval; HCWs = Healthcare Workers; HAIs = Healthcare Associated Infections
- 1 January 2014
- Published by American Society for Clinical Laboratory Science in American Society for Clinical Laboratory Science
- Vol. 27 (1) , 21-31
Open AccessStaphylococcus, not MRSA? A Final Report of Carriage and Conversion Rates in Nursing Students
OBJECTIVE: To evaluate and characterize staphylococcal carriage, possibly including methicillin-resistant Staphylococcus aureus (MRSA), and conversion rates in nursing students across clinical semester rotations and to describe risk factors. DESIGN: A prospective longitudinal cohort design with six times of measurement. Data collected August 2010 to May 2012. Institutional Review Board approval (2010F5693) SETTING: Texas State University, San Marcos, TX PARTICIPANTS: Eighty-seven nursing students. INTERVENTIONS: A positive MRSA swab was considered an end point for participation. Intervention offered was bactroban (mupirocin) for nasal decolonization and an oral antibiotic, doxycycline; follow-up post treatment collection sample was done to verify decolonization prior to next clinical rotation. MAIN OUTCOME MEASURES: Screening for Staphylococcus aureus and MRSA identification; confirmation and antibiotic susceptibility by Vitek 2; self-administered questionnaires delineating demographics and risk factors; panel logistic regression models by Stata version 13 RESULTS: MRSA colonization did not increase. S. aureus incidence was 17.7 – 26.4%. Staphylococcal species incidence other than S. aureus increased (9.2 – 82.3%). The following odds ratio (OR) associations were found to be statistically significant: boil or skin infections with S. aureus (OR = 2.94, p < .01), working or volunteering in a healthcare facility odds with species other than S. aureus (OR = 4.41, p < .01) and gym and sports facilities odds with S. other (OR 2.45, p < .01). The most frequently occurring species at Wave 5 was S. hominis (21 isolates) while the most frequently occurring species at Wave 6 was S. epidermidis (25 isolates). CONCLUSIONS: MRSA colonization did not increase during longitudinal study. S. aureus colonization remained fairly stable throughout the study (17 – 26%). Species colonization with non S. aureus species (e.g. S. hominis, S. epidermis, S. haemolyticus) increased significantly (9.2 – 82.3%) during clinical rotations. Knowledge of infection control and compliance may have contributed to an absence of MRSA colonization; however, the colonization by other staphylococci has been shown to be a risk factor for MRSA acquisition. ABBREVIATIONS: MRSA = Methicillin-resistant Staphylococcus aureus; CA-MRSA = Community-associated methicillin resistant Staphylococcus aureus; HA-MRSA = Healthcare-associated methicillin resistant Staphylococcus aureus; MSSA = methicillin-sensitive Staphylococcus aureus; CLS = Clinical Laboratory Science; OR = odds ratio; CI = Confidence Interval; HCWs = Healthcare Workers; HAIs = Healthcare Associated Infections
- 1 July 2012
- Published by American Society for Clinical Laboratory Science in American Society for Clinical Laboratory Science
- Vol. 25 (3) , 156-164
Snapshot Prevalence and Characterization of Staphylococcus species, including MRSA, in a Student Athletic Facility: An Undergraduate Research Project
OBJECTIVE: To evaluate and characterize the prevalence of MRSA, Staphylococcus aureus, and other Staphylococcus species found on exercise equipment on one day point of collection. DESIGN: A cross sectional, point prevalence design (pilot study) with a single time of measurement. Data collected in summer of 2011 (Undergraduate Research Project for CLS Program, CLS 4361 Clinical Research). Project received Institutional Review Board exemption. SETTING: In a higher education athletic facility in Texas. SAMPLES: One hundred twenty-five environmental samples were collected from various exercise equipment and areas within the facility. MAIN OUTCOME MEASURES: Samples were screened for Staphylococcus species using standard microbiological techniques. Confirmation of S. aureus was conducted by DRYSPOT Staphytect Plus™. MRSA isolates were confirmed with CHROMagar™; VITEK® 2 antibiotic susceptibility testing and PFGE characterized all MRSA isolates. RESULTS: Prevalence of MRSA was 6%, S. aureus 38%, other Staphylococcus species 52% and no growth 4%. Prevalence of S. aureus and MRSA was highest on free weights and mats, respectively. PFGE characterized all MRSA isolates as HA-MRSA (USA100 strain). CONCLUSIONS: Although limitations exist for this study with a single time of measurement for data, the findings indicate potential exposure risks from Staphylococcus species in college athletic facilities. Compliance (disinfection) and creative health education may reduce transmission of pathogens, environmental load, and incidence of colonization or infection in students. ABBREVIATIONS:CA-MRSA - Community-associated methicillin resistant Staphylococcus aureus; CLS - Clinical Laboratory Science; HAIs - Healthcare associated infections; HA-MRSA - Healthcare-associated methicillin resistant Staphylococcus aureus; MDRO - Multiple Drug Resistant Organisms; MRSA - Methicillin resistant Staphylococcus aureus.
- 1 July 2012
- Published by American Society for Clinical Laboratory Science in American Society for Clinical Laboratory Science
- Vol. 25 (3) , 156-164
Snapshot Prevalence and Characterization of Staphylococcus species, including MRSA, in a Student Athletic Facility: An Undergraduate Research Project
OBJECTIVE: To evaluate and characterize the prevalence of MRSA, Staphylococcus aureus, and other Staphylococcus species found on exercise equipment on one day point of collection. DESIGN: A cross sectional, point prevalence design (pilot study) with a single time of measurement. Data collected in summer of 2011 (Undergraduate Research Project for CLS Program, CLS 4361 Clinical Research). Project received Institutional Review Board exemption. SETTING: In a higher education athletic facility in Texas. SAMPLES: One hundred twenty-five environmental samples were collected from various exercise equipment and areas within the facility. MAIN OUTCOME MEASURES: Samples were screened for Staphylococcus species using standard microbiological techniques. Confirmation of S. aureus was conducted by DRYSPOT Staphytect Plus™. MRSA isolates were confirmed with CHROMagar™; VITEK® 2 antibiotic susceptibility testing and PFGE characterized all MRSA isolates. RESULTS: Prevalence of MRSA was 6%, S. aureus 38%, other Staphylococcus species 52% and no growth 4%. Prevalence of S. aureus and MRSA was highest on free weights and mats, respectively. PFGE characterized all MRSA isolates as HA-MRSA (USA100 strain). CONCLUSIONS: Although limitations exist for this study with a single time of measurement for data, the findings indicate potential exposure risks from Staphylococcus species in college athletic facilities. Compliance (disinfection) and creative health education may reduce transmission of pathogens, environmental load, and incidence of colonization or infection in students. ABBREVIATIONS:CA-MRSA - Community-associated methicillin resistant Staphylococcus aureus; CLS - Clinical Laboratory Science; HAIs - Healthcare associated infections; HA-MRSA - Healthcare-associated methicillin resistant Staphylococcus aureus; MDRO - Multiple Drug Resistant Organisms; MRSA - Methicillin resistant Staphylococcus aureus.
- Open Access
- 2 April 2012
- Published by Springer Nature in BMC Health Services Research
- Vol. 12 (1) , 88
MRSA model of learning and adaptation: a qualitative study among the general public
More people in the US now die from Methicillin Resistant Staphylococcus aureus (MRSA) infections than from HIV/AIDS. Often acquired in healthcare facilities or during healthcare procedures, the extremely high incidence of MRSA infections and the dangerously low levels of literacy regarding antibiotic resistance in the general public are on a collision course. Traditional medical approaches to infection control and the conventional attitude healthcare practitioners adopt toward public education are no longer adequate to avoid this collision. This study helps us understand how people acquire and process new information and then adapt behaviours based on learning.
- 2 April 2012
- Published by Springer Nature in BMC Health Services Research
- Vol. 12 (1) , 88
Open AccessMRSA model of learning and adaptation: a qualitative study among the general public
More people in the US now die from Methicillin Resistant Staphylococcus aureus (MRSA) infections than from HIV/AIDS. Often acquired in healthcare facilities or during healthcare procedures, the extremely high incidence of MRSA infections and the dangerously low levels of literacy regarding antibiotic resistance in the general public are on a collision course. Traditional medical approaches to infection control and the conventional attitude healthcare practitioners adopt toward public education are no longer adequate to avoid this collision. This study helps us understand how people acquire and process new information and then adapt behaviours based on learning.